- President Joe Biden said America needs to determine the origins of the COVID-19 pandemic to prevent future outbreaks when he announced that he signed the "COVID-19 Origin Act of 2023" into law with unanimous congressional support.
- "We need to get to the bottom of COVID-19’s origins to help ensure we can better prevent future pandemics," Biden said Monday.
Read More at justthenews.com
- A recent study explored the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human saliva.
- Several studies performed on nasal and pharyngeal samples noted a reduction in viral shedding along with a decline in culturable virus within the first week of COVID-19 symptoms.
- However, only a few studies have assessed the duration for which SARS-CoV-2 is detected in salivary samples in comparison to nasal swabs after the initial week of symptoms.
Read More at news-medical.net
- President Joe Biden signed a bipartisan bill Monday that directs the federal government to declassify as much intelligence as possible about the origins of COVID-19 more than three years after the start of the pandemic.
- The legislation, which passed both the House and Senate without dissent, directs the Office of the Director of National Intelligence to declassify intelligence related to China’s Wuhan Institute of Virology.
Read More at q13fox.com
- Paxlovid, a medication that has helped millions of high-risk COVID-19 patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration.
- An FDA advisory panel voted 16-1 that the Pfizer drug remains a safe and effective treatment and should be given full approval.
- It has only received emergency use authorization until now, but the FDA is expected to make a final decision on full approval by May.
Read More at healthday.com
- WHO advisors have urged China to release all Covid-related data after new research suggested that the virus may have been circulating in the country as early as August 2019.
- The research, which was published in the journal Nature Medicine, analyzed data from more than 10,000 patients in China and found that the virus was likely circulating in the country before the first known case was reported in Wuhan in December 2019.
Read More at reuters.com